BC’s success story shows strength of Treatment as Prevention

1 December 2021

On December 1st we celebrate World AIDS Day, an opportunity to reflect on our challenges and successes four decades into the battle against HIV/AIDS. Around the world there are nearly 38 million people living with HIV and about 1.5 million new infections per year. A recent report by the World Health Organization estimates the number of people with the virus being treated with antiretrovirals had risen to 27.5 million – an increase of almost 10% over the last year. Encouraging but not enough.

Read More »

BC-CfE researchers examine a novel antiviral compound discovery

4 November 2021

Dr. Peter Cheung, a staff scientist in the BC-CfE laboratory, recently published a paper as a co-first author on the topic of a novel antiviral compound discovery.Dr. Cheung worked with researchers at the University of BC and the University of Toronto to characterize chemical compounds that inhibit HIV in novel ways compared to antiretroviral agents currently used. Specifically, the molecules discussed in the paper “2-Trifluoromethylthiazole-5-carboxamides: Analogues of a Stilbene-Based Anti-HIV Agent that Impact HIV mRNA Processing” impact the processing and production of mRNA “messages” that instruct a cell to make proteins.

Read More »

BC-CfE research advances understanding of dynamics within HIV transmission clusters

19 October 2021

Understanding the dynamics within HIV transmission clusters is critical information that can help prioritize public health resource allocation. Although HIV sequence clustering is routinely used to identify subpopulations experiencing elevated transmission, there’s a risk of over-simplifying transmission dynamics within clusters as well as the risk that clustering methodology influences outcomes.

Read More »

Change of Leadership for BC-CfE’s Clinical Education and Training Program

8 October 2021

The BC-CfE’s Clinical Education and Training Program recently saw a change in leadership from Dr. Silvia Guillemi, who started leading the program when it began back in 2011, to Dr. Val Montessori. Dr. Montessori has multiple roles, as she will be leading the Clinical Education and Training Program while also serving as the Head of the Division of Infectious Diseases at St. Paul’s Hospital and as the Co-chair of the Committee for Drug Evaluation and Therapy. Dr. Montessori also works as a Clinical Associate professor in the Division of Infectious Diseases at the University of British Columbia. The Clinical Education and Training Program was designed to provide learning opportunities on the diagnosis, treatment, management and care of HIV/AIDS and related conditions through personalized learning programs.

Read More »

BC-CfE researchers examine HIV diagnoses rates among Indigenous peoples worldwide

6 October 2021

BC-CfE researchers recently published a study comparing rates and trends of HIV diagnoses among Indigenous Peoples in Canada, Australia, the USA, and New Zealand.

The study is titled “Rates of new HIV diagnoses among Indigenous Peoples in Canada, Australia, New Zealand, and the United States: 2009-2017” and the researchers used publicly available surveillance data to estimate the rate of HIV diagnoses per 100,000 people. Each of the four countries examined have passive population-based HIV surveillance programs.

Read More »
Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

Start typing and press enter to search